AVE 0.00% 0.3¢ avecho biotechnology limited

Ann: March 2024 Quarterly Activities Report & Appendix 4C, page-19

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,171 Posts.
    lightbulb Created with Sketch. 68
    The BOD study didn't do that coy much good kairos , they are presently in administration !
    The avecho issue is can tpm compete with other compounds that significantly increase cbd absorption ? Where's the case supporting tpm ?
    If the study proves successful it won't be about tpm but cbd absorption mitigating insomnia . Get it ?
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.